Results 241 to 250 of about 7,661,261 (288)
Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher +10 more
wiley +1 more source
AFX catheter retention with type III endoleak. [PDF]
Matsuda Y, Esaki J.
europepmc +1 more source
Functional and Structural Evidence of Neurofluid Circuit Aberrations in Huntington Disease
ABSTRACT Objective Disrupted neurofluid regulation may contribute to neurodegeneration in Huntington disease (HD). Because neurofluid pathways influence waste clearance, inflammation, and the distribution of central nervous system (CNS)–delivered therapeutics, understanding their dysfunction is increasingly important as targeted treatments emerge.
Kilian Hett +8 more
wiley +1 more source
Principles for Optimal Drug Selection in IgA Nephropathy-Time for Integrating Pathogenesis and Clinical Markers to Guide Therapy. [PDF]
Suzuki Y.
europepmc +1 more source
VGLUT1 and PSD-95 Expression Remains Stable in the Prefrontal and Cerebellar Cortices of the VPA Autism Rat Model. [PDF]
Reveley M +4 more
europepmc +1 more source
Benchmarking large language models for pathogen-disease classification in post-acute infection syndromes. [PDF]
Mohammed Khalid S +4 more
europepmc +1 more source
The research program subjective theories: A methodological concept for a wide range of applications. [PDF]
Gadewoltz PN.
europepmc +1 more source

